Steve E. Unger

Bristol-Myers Squibb (United States)

Papers

1

Total Citations

92

H-Index

1

About

Steve E. Unger is a pioneering figure in high-throughput bioanalytical chemistry, with a career defined by transformative advances in liquid chromatography/tandem mass spectrometry (LC/MS/MS) and automated sample preparation. His most cited work, a 2002 study, introduced a groundbreaking system capable of extracting and analyzing 1152 plasma samples in just 10 hours—achieving a remarkable 30-second-per-sample throughput. By integrating a Zymark track robot with a Tecan Genesis liquid handler for parallel solid-phase extraction, Unger’s method set a new standard for speed and efficiency in bioanalysis, directly enabling large-scale pharmacokinetic and drug metabolism studies. This work, garnering 92 citations, exemplifies his broader contributions to accelerating drug development pipelines through automation and high-performance separation techniques. Unger’s innovations have profoundly impacted pharmaceutical research, reducing analysis times from hours to seconds while maintaining robust analytical precision. His legacy lies in bridging the gap between complex sample preparation and rapid, reliable mass spectrometric detection, making him a key architect of modern high-throughput bioanalytical workflows.

Research Focus

Key Achievements

1
H-Index
1
Papers
92
Total Citations
92
Avg Citations/Paper
🏆 Most Cited Paper
High‐speed gradient parallel liquid chromatography/tandem mass spectrometry with fully automated sample preparation for bioanalysis: 30 seconds per sample from plasma
92 citations · 2002
📈 Most Prolific Year: 2002 (1 Papers)
🤝 Key Collaborators: 5
🏛 Institutions: Bristol-Myers Squibb (United States)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago